Will the Chinese government formally ban foreign acquisitions of critical biopharma platforms by 2026-11-15?

Awaiting liquidity · Closes Nov 15, 2026

This book is open and awaiting liquidity. Outcome labels are listed; displayed prices appear once the book is funded.

Outcomes: Yes · No

Resolution

Closes Nov 15, 2026. The QEHFX operator resolves the outcome from the stated criteria (Two independent major news agencies). A dispute window stays open before payouts finalise.

The question resolves YES if, by 2026-11-15, China's central government (e.g., State Council, Ministry of Commerce, NDRC) has issued a binding regulation, law, or official policy that prohibits or restricts foreign entities from acquiring controlling stakes in biopharma platforms designated as critical. The ban must be in effect, not merely proposed or under discussion. Otherwise, resolves NO.

Trades are priced and settled on the QEHFX custodial ledger; balances, deposits, and withdrawals are verified on-chain on opBNB.

Related markets

• Will the Trump Administration take action to protect China deals pushed by pharmaceutical companies by October 23, 2026?
• Will a pan-African genomic data-sharing platform publicly report that it links genomic data from at least five African countries by 2026-11-10?
• By 2026-10-22, will an official South Korean government body publicly confirm that a China-based suspect used AI tools in the South Korean bank hacks?
• By October 18, 2026, will the Chinese government issue an official nationwide plan or policy framework explicitly aimed at ensuring China does not face a severe food shortage?
• Will Narendra Modi still be the Prime Minister of India on 2026-10-18?

← All markets